incidentally Lymphoma has been mentioned in the past albeit 2014
https://www.patrys.com/site/market-announcements/2014/380_PAB_ASX_Press_Release_LM1_development_-_V8_Final.pdf
an extract here :- The most recent laboratory experiments focused on the evaluation of the efficacy of PAT-LM1 in
blood cancers including different types of leukaemias and lymphomas. PAT-LM1 showed very strong
and specific binding to more than 90% of tested lymphoma cell lines and patients samples. PAT-LM1
was able to induce cell death in mantle cell lymphoma and histiocytic lymphoma cells. Interestingly,
PAT-LM1 also bound specifically and strongly to some very rare lymphoma types like marginal zone
B-cell and Burkitt lymphoma, indicating that it may have broad therapeutic application covering the
whole range of different lymphomas. Despite there being numerous drugs on the market for
lymphoma, there is still a significant unmet medical need especially in patients with relapsed and
refractory disease. The prognosis for these patients is poor and therefore the development of novel
agents, such as PAT-LM1, is urgently needed
- Forums
- Charts
- PAB chart
incidentally Lymphoma has been mentioned in the past albeit...
- There are more pages in this discussion • 329 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAB (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.9¢ |
Change
0.001(12.5%) |
Mkt cap ! $18.51M |
Open | High | Low | Value | Volume |
0.8¢ | 0.9¢ | 0.8¢ | $2.59K | 308.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 654316 | 0.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.9¢ | 1426680 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 654316 | 0.008 |
22 | 6453441 | 0.007 |
10 | 2287680 | 0.006 |
8 | 3155992 | 0.005 |
5 | 4324000 | 0.004 |
Price($) | Vol. | No. |
---|---|---|
0.009 | 1426680 | 2 |
0.010 | 1610744 | 3 |
0.011 | 1610000 | 5 |
0.012 | 372407 | 3 |
0.013 | 990000 | 2 |
Last trade - 15.56pm 07/05/2024 (20 minute delay) ? |
Featured News
PAB (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
Previous Video
Next Video
SPONSORED BY The Market Online